Best pharmaceutical companies in Kansas

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

cGMP Validation was established in 1997 as a full service validation/compliance firm offering services for the pharmaceutical, bulk pharmaceutical, animal health, biotechnology, biologics, medical device and medical diagnostic industries. cGMP Validation specializes in the preparation and execution of validation IQ/OQ/PQ protocols, compliance documentation for equipment, utilities, processes, laboratory instruments, and computer systems.

Vince & Associates Clinical Research, Inc is primarily engaged in commercial physical and biological research and development on a contract or fee basis.

EMB Statistical Solutions, LLC is primarily engaged in furnishing business consulting services, not elsewhere classified, on a contract or fee basis.

Tri-Ko, Inc. is a not-for-profit agency serving individuals with developmental disabilities in Miami, Linn and Anderson Counties.

CritiTech, Inc. conducts research and development into the production and application of fine-particle compounds. The company has expanded its operations to include applications in fine particle API production, coatings, and internal product development.

Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter. With a world-class, FDA-accredited manufacturing facility in Sydney and operations in the United States, Canada, Middle East and Asia-Pacific, Parnell is committed to continued development of innovative products at the highest standard. Parnell currently markets products for companion, performance and production animals enhanced with proprietary software platforms designed to improve compliance and clinical outcomes. Parnell is poised to bring several new products to market over the next five years addressing up to twelve indications and needs, with a particular focus on the companion animal sector. At Parnell, we believe the combination of our current product portfolio, pipeline of product candidates and business solutions position us to become a leading innovator in animal health. Our value-added approach establishes us as a business partner with our customers, not a commodity provider. That is the Parnell difference.